These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30769058)

  • 41. A Pilot Study of Femoropopliteal Artery Revascularisation with a Low Dose Paclitaxel Coated Balloon: Is Predilatation Necessary?
    Schroeder H; Meyer DR; Lux B; Ruecker F; Martorana M; Miller LE; Duda S
    Eur J Vasc Endovasc Surg; 2017 Sep; 54(3):348-355. PubMed ID: 28778456
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of drug-eluting balloon angioplasty with self-expanding interwoven nitinol stent deployment in patients with complex femoropopliteal lesions.
    Teymen B; Akturk S; Akturk U; Tdjani M
    Vascular; 2018 Feb; 26(1):54-61. PubMed ID: 28708023
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The use of the GORE® TIGRIS® Vascular Stent with dual component design in the superficial femoral and popliteal arteries at 6 months.
    Piorkowski M; Freitas B; Schmidt A; Bräunlich S; Ulrich M; Schuster J; Bausback Y; Werner M; Scheinert D
    J Cardiovasc Surg (Torino); 2013 Aug; 54(4):447-53. PubMed ID: 24013533
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Risk Factors for Restenosis after Drug-coated Balloon Angioplasty for Complex Femoropopliteal Arterial Occlusive Disease.
    Roh JW; Ko YG; Ahn CM; Hong SJ; Shin DH; Kim JS; Kim BK; Choi D; Hong MK; Jang Y
    Ann Vasc Surg; 2019 Feb; 55():45-54. PubMed ID: 30118857
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Patterns of femoropopliteal recurrence after routine and selective stenting endoluminal therapy.
    Kiguchi MM; Marone LK; Chaer RA; Winger DG; Shi ZY; Celis RI; Makaroun MS; Rhee RY
    J Vasc Surg; 2013 Jan; 57(1):37-43. PubMed ID: 22975333
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intravascular ultrasound measurements after drug-eluting stent placement in femoropopliteal lesions: determining predictors of restenosis.
    Mori S; Hirano K; Nakano M; Muramatsu T; Tsukahara R; Ito Y; Ishimori H
    J Endovasc Ther; 2015 Jun; 22(3):341-9. PubMed ID: 25862363
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of Clinical Outcomes between Endovascular Therapy with Self-Expandable Nitinol Stent and Femoral-Popliteal Bypass for Trans-Atlantic Inter-Society Consensus II C and D Femoropopliteal Lesions.
    Okuno S; Iida O; Iida T; Takahara M; Yamaoka T; Kitano I; Asai M; Masuda M; Okamoto S; Ishihara T; Nanto K; Kanda T; Tsujimura T; Matsuda Y; Mano T
    Ann Vasc Surg; 2019 May; 57():137-143. PubMed ID: 30500627
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Directional atherectomy versus balloon angioplasty in segmental femoropopliteal artery disease: two-year follow-up with color-flow duplex scanning.
    Vroegindeweij D; Tielbeek AV; Buth J; Schol FP; Hop WC; Landman GH
    J Vasc Surg; 1995 Feb; 21(2):255-68; discussion 268-9. PubMed ID: 7853599
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Primary Retrograde Tibio-Pedal Approach for Endovascular Intervention of Femoropopliteal Disease with Chronic Total Occlusion.
    Htun WW; Kyaw H; Aung YL; Maw M; Kwan T
    Cardiovasc Revasc Med; 2020 Feb; 21(2):171-175. PubMed ID: 31699649
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 1-Year Results of a Multicenter Randomized Controlled Trial Comparing Heparin-Bonded Endoluminal to Femoropopliteal Bypass.
    Reijnen MMPJ; van Walraven LA; Fritschy WM; Lensvelt MMA; Zeebregts CJ; Lemson MS; Wikkeling ORM; Smeets L; Holewijn S
    JACC Cardiovasc Interv; 2017 Nov; 10(22):2320-2331. PubMed ID: 29169500
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anterolateral retrograde access to the distal popliteal artery and to the tibioperoneal trunk for recanalization of femoropopliteal chronic total occlusions.
    Silvestro M; Palena LM; Manzi M; Gómez-Jabalera E; Vishwanath D; Casini A; Ferraresi R
    J Vasc Surg; 2018 Dec; 68(6):1824-1832. PubMed ID: 30126786
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of intravascular ultrasound in femoropopliteal stenting for peripheral artery disease with TASC II class A to C lesions.
    Iida O; Takahara M; Soga Y; Suzuki K; Hirano K; Kawasaki D; Shintani Y; Suematsu N; Yamaoka T; Nanto S; Uematsu M
    J Endovasc Ther; 2014 Aug; 21(4):485-92. PubMed ID: 25101575
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Paclitaxel-Eluting Balloon Versus Standard Balloon Angioplasty in In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Artery: 1-Year Results of the PACUBA Trial.
    Kinstner CM; Lammer J; Willfort-Ehringer A; Matzek W; Gschwandtner M; Javor D; Funovics M; Schoder M; Koppensteiner R; Loewe C; Ristl R; Wolf F
    JACC Cardiovasc Interv; 2016 Jul; 9(13):1386-92. PubMed ID: 27388828
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Retrograde popliteal approach for challenging occlusions of the femoral-popliteal arteries.
    Ye M; Zhang H; Huang X; Shi Y; Yao Q; Zhang L; Zhang J
    J Vasc Surg; 2013 Jul; 58(1):84-9. PubMed ID: 23806253
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The use of endografts to create an endoluminal femoropopliteal bypass after failed above-knee femoropopliteal open bypass surgery.
    Lensvelt MM; Wikkeling OR; Van Oostayen JA; Roukema JG; Zeebregts CJ; Reijnen MM
    Vasc Endovascular Surg; 2012 May; 46(4):338-41. PubMed ID: 22504512
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Stent fractures after superficial femoral artery stenting: risk factors and impact on patency.
    Lin Y; Tang X; Fu W; Kovach R; George JC; Guo D
    J Endovasc Ther; 2015 Jun; 22(3):319-26. PubMed ID: 25862365
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Stent placement in the superficial femoral and proximal popliteal arteries with the innova self-expanding bare metal stent system.
    Powell RJ; Jaff MR; Schroë H; Benko A; Diaz-Cartelle J; Müller-Hülsbeck S
    Catheter Cardiovasc Interv; 2017 May; 89(6):1069-1077. PubMed ID: 28296239
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Atherectomy of heavily calcified femoropopliteal stenotic lesions.
    Minko P; Katoh M; Jaeger S; Buecker A
    J Vasc Interv Radiol; 2011 Jul; 22(7):995-1000. PubMed ID: 21592824
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
    McQuade K; Gable D; Hohman S; Pearl G; Theune B
    J Vasc Surg; 2009 Jan; 49(1):109-15, 116.e1-9; discussion 116. PubMed ID: 19028055
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Endovascular treatment of popliteal artery segments P1 and P2 in patients with critical limb ischemia: initial experience using a helical nitinol stent with increased radial force.
    Goltz JP; Ritter CO; Kellersmann R; Klein D; Hahn D; Kickuth R
    J Endovasc Ther; 2012 Jun; 19(3):450-6. PubMed ID: 22788900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.